Sabira Kurtovic

The Efficacy of Generic Imatinib as First- and Second-line Therapy: 3-Year Follow-up of Patients With Chronic Myeloid Leukemia

Erna Islamagić, Azra Hasić, Sabira Kurtovic et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 25 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Medicine +9

Lack of Access to Targeted Cancer Treatment Modalities in the Developing World in the Era of Precision Medicine: Real-Life Lessons From Bosnia

Amina Kurtović-Kozarić, Semir Vranić, Sabira Kurtovic et al. · Journal of Global Oncology · 2017 · 20 citations · Full text

Real-life Lessons, Developing World, Medicine +7

The reality of cancer treatment in a developing country: the effects of delayed <scp>TKI</scp> treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients

Amina Kurtović-Kozarić, Azra Hasić, Jerald P. Radich et al. · British Journal of Haematology · 2015 · 19 citations

A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma

Graham P. Collins, Toby A. Eyre, Debora Schmitz-Rohmer et al. · HemaSphere · 2021 · 18 citations · Full text

Immunodeficiencies, Immunology, Pathology +20